Intuitive Surgical, Inc. $ISRG Holdings Reduced by Arlington Financial Advisors LLC

Arlington Financial Advisors LLC decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 27.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 12,263 shares of the medical equipment provider’s stock after selling 4,704 shares during the period. Intuitive Surgical makes up approximately 1.1% of Arlington Financial Advisors LLC’s holdings, making the stock its 27th biggest position. Arlington Financial Advisors LLC’s holdings in Intuitive Surgical were worth $6,664,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ISRG. Chilton Capital Management LLC increased its stake in shares of Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares during the period. Elite Financial Inc. acquired a new position in shares of Intuitive Surgical during the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA acquired a new position in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. TD Capital Management LLC increased its stake in shares of Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares in the company, valued at $325,669.91. This represents a 31.19% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock worth $21,716,492 in the last quarter. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $436.39 on Wednesday. The company has a 50 day moving average price of $456.92 and a 200 day moving average price of $497.02. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a market capitalization of $156.44 billion, a price-to-earnings ratio of 60.86, a P/E/G ratio of 4.58 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same quarter last year, the business posted $1.78 EPS. The company’s revenue was up 21.4% on a year-over-year basis. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research analyst reports. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. The Goldman Sachs Group reduced their target price on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a report on Wednesday, October 1st. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Wednesday, October 8th. BTIG Research reduced their target price on shares of Intuitive Surgical from $571.00 to $529.00 and set a “buy” rating for the company in a report on Monday. Finally, UBS Group set a $529.00 target price on shares of Intuitive Surgical in a report on Monday. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $585.71.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.